Plaintiffs Lose Class Cert. Bid in Mo. Neurontin Case
By Elaine Meyer ( July 30, 2010, 4:17 PM EDT) -- A Missouri judge has denied class certification to plaintiffs who sued Pfizer Inc. arguing they overpaid to use epilepsy drug Neurontin for off-label purposes for which the drug was ineffective....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.